Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Neurocrine BiosciencesBIO-TECHNEbluebird bioQiagenSeattle Genetics
SymbolNASDAQ:NBIXNASDAQ:TECHNASDAQ:BLUENYSE:QGENNASDAQ:SGEN
Price Information
Current Price$88.12$210.03$139.45$39.58$75.17
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$107.2105$201.25$157.2079$41.50$85.80
% Upside from Price Target21.66% upside-4.18% downside12.73% upside4.85% upside14.14% upside
Trade Information
Market Cap$7.95 billion$7.95 billion$7.43 billion$8.91 billion$10.32 billion
Beta1.341.172.290.842.05
Average Volume860,955174,843540,0111,206,018875,932
Sales & Book Value
Annual Revenue$451.24 million$642.99 million$54.58 million$1.50 billion$654.70 million
Price / Sales17.8312.37140.845.9418.52
Cashflow$0.5046 per share$5.8212 per shareN/A$2.4267 per shareN/A
Price / Cash174.6436.08N/A16.31N/A
Book Value$5.30 per share$28.72 per share$34.47 per share$11.69 per share$7.95 per share
Price / Book16.637.314.053.399.46
Profitability
Net Income$21.11 million$126.15 million$-555,630,000.00$190.38 million$-222,690,000.00
EPS$0.22$4.07($10.68)$1.34($1.65)
Trailing P/E Ratio400.5551.60N/A29.54N/A
Forward P/E Ratio29.5745.86N/A24.74N/A
P/E GrowthN/A$3.83N/A$2.46N/A
Net Margins-7.56%17.15%-1,184.01%12.45%-17.52%
Return on Equity (ROE)-9.14%13.53%-34.01%12.22%-16.09%
Return on Assets (ROA)-4.21%8.35%-28.49%5.77%-13.75%
Dividend
Annual PayoutN/A$1.28N/AN/AN/A
Dividend YieldN/A0.61%N/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A31.45%N/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.96%0.44%0.09%0.54%N/A
Current Ratio8.79%4.32%9.31%1.69%3.27%
Quick Ratio8.61%3.36%9.31%1.52%2.95%
Ownership Information
Institutional Ownership Percentage95.86%92.73%N/A63.20%99.79%
Insider Ownership Percentage4.30%3.80%3.00%9.00%33.80%
Miscellaneous
Employees5852,0007644,9521,302
Shares Outstanding91.29 million37.87 million55.12 million225.51 million161.32 million
Next Earnings Date7/29/2019 (Confirmed)8/6/2019 (Estimated)8/1/2019 (Estimated)7/30/2019 (Confirmed)10/24/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
 Neurocrine BiosciencesBIO-TECHNEbluebird bioQiagenSeattle Genetics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel